<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="71187">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02179034</url>
  </required_header>
  <id_info>
    <org_study_id>1307012312</org_study_id>
    <nct_id>NCT02179034</nct_id>
  </id_info>
  <brief_title>Flavors and E-cigarette Effects in Adolescent Smokers</brief_title>
  <official_title>Flavors and E-cigarette Effects in Adolescent Smokers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to examine if inhaled doses of menthol that produce low and high cooling
      effects change the appeal of e-cigarettes containing low and high doses of nicotine in
      adolescent smokers. The hypothesis is that the combination of nicotine and menthol, when
      compared with menthol or nicotine alone, will result in greater increase in liking of an
      e-cigarette and greater reduction in nicotine withdrawal.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liking/effect score of the e-cigarette</measure>
    <time_frame>Every 30 min for 120 min during lab session</time_frame>
    <description>The Drug Effects Questionnaire (Soria et al) will be used to ask about participants' liking/effect of the e-cigarettes smoked during the 4 bouts of e-cigarette puffing during the lab session to determine which menthol dose is most preferred. A linear mixed-effects regression model wil be used with nicotine group (none, low, high) as between-subject factor, and menthol dose (none, low dose, high dose) as within-subject factor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Maximum value of money at which the e-cigarette is chosen over money</measure>
    <time_frame>Every 30 min for 120 min during lab session</time_frame>
    <description>E-cigarette value will be determined using the Multiple Choice Procedure (Griffiths et al, 1993) to determine the reinforcing value of the e-cigarette. The MCP involves sampling the e-cigarette and then making a discrete choice between the e-cigarette or a series of monetary values.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change scores from baseline in Nicotine Withdrawal</measure>
    <time_frame>Every 30 min for 120 min during lab session</time_frame>
    <description>The Minnesota Nicotine Withdrawal Scale (Hughes et al,1986) will be used to assess the magnitude of change in nicotine withdrawal symptoms during the lab session</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change scores from baseline in Tobacco Craving</measure>
    <time_frame>Every 30 min for 120 min during lab session</time_frame>
    <description>The Brief Questionnaire on Smoking Urges (Tiffany &amp; Drobes,1991) will be used to assess the magnitude of change in tobacco craving during the lab session</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Nicotine Dependence, Cigarettes</condition>
  <arm_group>
    <arm_group_label>Tobacco Flavor</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In this arm, subjects will receive tobacco flavor- without nicotine (placebo). Participants will then be exposed to 3 levels of a menthol additive in random order: no dose, low dose and high dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Dose Nicotine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this arm, subjects will receive a low dose of nicotine (6 mg/ml) added to the tobacco flavor. Participants will then be exposed to 3 levels of a menthol additive in random order: no dose, low dose and high dose.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Dose Nicotine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this arm, subjects will receive a high dose of nicotine (12 mg/ml) added to the tobacco flavor. Participants will then be exposed to 3 levels of a menthol additive in random order: no dose, low dose and high dose.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine</intervention_name>
    <description>Participants will receive no nicotine, low dose nicotine (6 mg/ml) or high dose nicotine (12 mg/ml)</description>
    <arm_group_label>Low Dose Nicotine</arm_group_label>
    <arm_group_label>High Dose Nicotine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Dose Menthol</intervention_name>
    <description>A low dose of menthol will be added to the tobacco flavor.</description>
    <arm_group_label>Tobacco Flavor</arm_group_label>
    <arm_group_label>Low Dose Nicotine</arm_group_label>
    <arm_group_label>High Dose Nicotine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Dose Menthol</intervention_name>
    <description>A high dose of menthol will be added to the tobacco flavor.</description>
    <arm_group_label>Tobacco Flavor</arm_group_label>
    <arm_group_label>Low Dose Nicotine</arm_group_label>
    <arm_group_label>High Dose Nicotine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 18-20 years

          -  Able to read and write

          -  Cigarette smoker

          -  Use of e-cigarettes in the past 30 days

        Exclusion Criteria:

          -  Seeking smoking cessation treatment

          -  Current/lifetime criteria for dependence on another psychoactive substance -Daily use
             of alcohol or marijuana or use of any other drugs including cocaine, opiates,
             stimulants

          -  Regular use of psychoactive drugs including anxiolytics, antidepressants and other
             psychostimulants

          -  Current or past history of psychosis or other psychiatric diagnosis such as major
             depression

          -  Any significant current medical condition
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>20 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Cavallo, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amanda Liss, B.A.</last_name>
    <phone>203-974-7418</phone>
    <email>amanda.liss@yale.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>CMHC</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Liss, B.A.</last_name>
      <phone>203-974-7418</phone>
      <email>amanda.liss@yale.edu</email>
    </contact>
    <contact_backup>
      <last_name>Dana Cavallo, PhD</last_name>
      <phone>203-974-7607</phone>
      <email>dana.cavallo@yale.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Suchitra Krishnan-Sarin, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 24, 2016</lastchanged_date>
  <firstreceived_date>June 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tobacco</keyword>
  <keyword>electronic cigarettes</keyword>
  <keyword>menthol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Nicotine</mesh_term>
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
